XML 32 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Unaudited Statements Of Consolidated Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash Flows From Operating Activities:    
Net income (loss) $ (11,137,286) $ (1,165,405)
Adjustments to reconcile net income to net cash provided by (used for) operating activities    
Stock-based compensation expense 521,704 0
Amortization of intangible assets 96,009 0
Amortization of debt discount 3,068,510 905,000
Acquisition consideration paid in common stock 5,800,000 0
Changes in operating assets and liabilities    
(Increase)/decrease in prepaid expenses (1,147,796) 0
Accrued interest (58,052) 0
Mortgages payable (476,450) 0
Accounts payable related party 95,382 0
Loan payable related party 75,000 0
Accrued expenes related party 294,591 0
Increase/(Decrease) in accounts payable and accrued expenses 46,994 54,163
Net cash provided by (used for) operating activities (2,821,394) (206,242)
Cash Flows From Investing Activities:    
Purchase of fixed assets (2,766) 0
Capitalized mortgage interest and changes in construction in progress (36,673) 0
Net cash provided by (used for) investing activities (39,439) 0
Cash Flows From Financing Activities:    
Refundable deposit on acquisition 0 (76,699)
Proceeds from the sale of convertible notes 1,200,000 905,000
Proceeds from the sale of notes payable 1,000,000 0
Purchase of treasury shares (98,955) 0
Proceeds from related party loans 75,000 0
Proceeds from the sale of preferred stock 475,000 60,000
Net cash provided by (used for) financing activities 2,651,045 888,301
Effect of exchange rates on cash and cash equivalents (61,827) 0
Net Increase (Decrease) In Cash (209,788) 682,059
Cash At The Beginning Of The Period 464,118 0
Cash At The End Of The Period 192,503 682,059
Supplemental disclosure of cash flow information:    
Cash paid for interest 66,016 0
Cash paid for income taxes 0 0
Supplemental disclosure of non-cash investing and financing activities:    
Common stock issued related to investment in Great Northern Cannabis 11,264,438 0
Common stock issued to convert convertible notes and accrued interest into equity $ 2,202,212 $ 0